OptiNose, Inc. (OPTN)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 1.0600 |
| Open | 1.0700 |
| Bid | 1.1600 x 400 |
| Ask | 1.2000 x 300 |
| Day's range | 1.0400 - 1.2100 |
| 52-week range | 0.8000 - 2.1000 |
| Volume | |
| Avg. volume | 1,186,141 |
| Market cap | 132.256M |
| Beta (5Y monthly) | -0.14 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.2700 |
| Earnings date | 08 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 3.50 |
Simply Wall St.When Will OptiNose, Inc. (NASDAQ:OPTN) Breakeven?
OptiNose, Inc. ( NASDAQ:OPTN ) is possibly approaching a major achievement in its business, so we would like to shine...
GlobeNewswireOptinose to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
YARDLEY, Pa., May 17, 2024 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that members of its management team will present a company overview and business update at the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ on May 20, 2024 at 11:30 a.m. ET. To listen to a webcast of the presentation live, please visit the Investors page of the Optinose website. A
© 2024 Yahoo. All rights reserved.